Strategy for Pooled Procurement of Essential Medicines and
Health Commodities, 2013-2017
12
tablets.
Through the regional pharmaceutical procurement agency, improvements will be achieved in PSM systems. Member
States with small populations will benefit from the economies of scale that are generated through joint procurement.
There will also be increased availability of orphan drugs, which are otherwise hard to obtain due to the small quantities
that individual Member States require.
The SADC regulatory harmonisation initiatives will facilitate access to quality-assured, safe and effective medicines.
4. VALUES AND PRINCIPLES
The core values and principles that guide the regional integration and cooperation agenda of SADC, as stated in the
SADC Treaty and the RISDP, shall underpin the Strategy for Pooled Procurement:
t
t
t
t
t
t
t
)VNBOSJHIUT
5SBOTQBSFODZ
&RVJUZ
(FOEFS
4VTUBJOBCMFPXOFSTIJQ
&GmDJFODZBOERVBMJUZ
BOE
5IFQSJODJQMFPGTVCTJEJBSJUZ
5. VISION
The vision underpinning the SADC Strategy for Pooled Procurement of Essential Medicines and Health Commodities is
that of a Southern African region that is able to maintain the highest standards of health for all.
6. PURPOSE
The purpose of the SADC Strategy for Pooled Procurement of Essential Medicines and Health Commodities is to
contribute to improving the availability of, and access to affordable, quality, safe and efficacious essential medicines.
7. STRATEGIC OBJECTIVES
The following strategic objectives will allow SADC to achieve the vision and purpose of the SADC Strategy for Pooled
Procurement of Essential Medicines and Health Commodities:
t
t
t
t
&TUBCMJTIBNFDIBOJTNGPSSFHJPOBMQSPDVSFNFOUPGNFEJDJOFTBOESFMBUFEIFBMUIDPNNPEJUJFT
.PCJMJTFBOEDPPSEJOBUFSFTPVSDFTGPSUIF4"%$SFHJPOBMQSPDVSFNFOUGPSFTTFOUJBMNFEJDJOFTBOEIFBMUI
DPNNPEJUJFT
%FWFMPQBOEIBSNPOJTFQPMJDJFT
HVJEFMJOFTBOEMFHJTMBUJPOGPSQSPDVSFNFOUPGFTTFOUJBMNFEJDJOFTBOEIFBMUI
DPNNPEJUJFT BOE
'BDJMJUBUFUSBEFBOENPWFNFOUPGFTTFOUJBMNFEJDJOFTBOEIFBMUIDPNNPEJUJFTJOUIFSFHJPO
In line with the strategic objectives, the key outcomes of the Strategy will be:
t
t
t
t
t
*NQSPWFEDPPSEJOBUJPOPGSFHJPOBMBDUJWJUJFT
*NQSPWFEDBQBDJUZGPSQSPDVSFNFOUPGFTTFOUJBMNFEJDJOFTBOEIFBMUIDPNNPEJUJFT
*NQSPWFESFTPVSDFTGPSUIF4"%$SFHJPOBMQSPDVSFNFOUPGFTTFOUJBMNFEJDJOFTBOEIFBMUIDPNNPEJUJFT
%FWFMPQFEBOEIBSNPOJTFE4"%$QPMJDJFT
HVJEFMJOFTBOEMFHJTMBUJPOGPSUIFQSPDVSFNFOUPGFTTFOUJBMNFEJDJOFT
and
&OIBODFEUSBEFGBDJMJUBUJPOBOENPWFNFOUPGFTTFOUJBMNFEJDJOFTBOEIFBMUIDPNNPEJUJFT
The corresponding major outputs, key performance indicators, time frame and indicative costs for the realisation of the
stated outcomes or results are described in the Results Framework below.